ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 54909 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 54909; 2) Community: the network communities that were significantly associated with the response to NSC 54909; 3) Molecule: the relationships between components within communities and NSC 54909; 4) MDR: the compounds that were significantly associated with the NSC 54909.

NSC Compound Enrichment Correlation
NSC 748722 Null 0.0385613993886 0.53749803
NSC 100880 Camptothecin 0.0385613993886001 0.16227257
NSC 126728 WLN: T B-18-56 C6 A 2BC D& AX CX EOV KOV QVO VO MU OU A&UTJ B1 GQH1 B&1 A-& BT3OX CHJ 0.0385613993886001 0.44315395
NSC 132313 Dianhydrogalactitol 0.0385613993886001 0.19824016
NSC 18805 .gamma.-Thujaplicine 0.0385613993886001 0.47035886
NSC 300289 Pinafide 0.0385613993886001 0.12638531
NSC 331935 CHALCONE ANALOG 0.0385613993886001 0.4841957
NSC 342610 Null 0.0385613993886001 0.052753075
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0385613993886001 0.00059419907
NSC 371777 Null 0.0385613993886001 0.3265238
Total:162  Current:124    [First] [Prev] [Next] [Last]